Literature DB >> 33719235

[Experimental study on repairing rabbit skull defect with bone morphogenetic protein 2 peptide/functionalized carbon nanotube composite].

Yuntao Di1, Cunyang Wang2, Huixue Zhu1, Suxiang Yu3, Yixing Ren4, Xiaoming Li5.   

Abstract

OBJECTIVE: To observe and compare the effects of peptides on the repair of rabbit skull defects through two different binding modes of non-covalent and covalent, and the combination of carboxyl (-COOH) and amino (-NH 2) groups with materials.
METHODS: Twenty-one 3-month-old male ordinary New Zealand white rabbits were numbered 1 to 42 on the left and right parietal bones. They were divided into 5 groups using a random number table, the control group (group A, 6 sides) and the material group 1, 2, 3, 4 (respectively group B, C, D, E, 9 sides in each group). All animals were prepared with 12-mm-diameter skull defect models, and bone morphogenetic protein 2 (BMP-2) non-covalently bound multiwalled carbon nanotubes (MWCNT)-COOH+poly ( L-lactide) (PLLA), BMP-2 non-covalently bound MWCNT-NH 2+PLLA, BMP-2 covalently bound MWCNT-COOH+PLLA, and BMP-2 covalently bound MWCNT-NH 2+PLLA were implanted into the defects of groups B, C, D, and E, respectively. At 4, 8, and 12 weeks after operation, the samples were taken for CT scanning and three-dimensional reconstruction, the ratio of bone tissue regeneration volume to total volume and bone mineral density were measured, and the histological observation of HE staining and Masson trichrome staining were performed to quantitatively analyze the volume ratio of new bone tissue.
RESULTS: CT scanning and three-dimensional reconstruction showed that with the extension of time, the defects in groups A-E were filled gradually, and the defect in group E was completely filled at 12 weeks after operation. HE staining and Masson trichrome staining showed that the volume of new bone tissue in each group gradually increased with time, and regenerated mature bone tissue appeared in groups D and E at 12 weeks after operation. Quantitative analysis showed that at 4, 8, and 12 weeks after operation, the ratio of bone tissue regeneration volume to total volume, bone mineral density, and the volume ratio of new bone tissue increased gradually over time; and at each time point, the above indexes increased gradually from group A to group E, and the differences between groups were significant ( P<0.05).
CONCLUSION: Through covalent binding and using -NH 2 to bound peptides with materials, the best bone repair effect can be achieved.

Entities:  

Keywords:  Bone morphogenetic protein 2; bone repair; multi-walled carbon nanotubes; peptide; rabbit; skull defect; three-dimensional reconstruction

Mesh:

Substances:

Year:  2021        PMID: 33719235      PMCID: PMC8171758          DOI: 10.7507/1002-1892.202009014

Source DB:  PubMed          Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi        ISSN: 1002-1892


  27 in total

1.  Controlling the phenotype and function of mesenchymal stem cells in vitro by adhesion to silane-modified clean glass surfaces.

Authors:  J M Curran; R Chen; J A Hunt
Journal:  Biomaterials       Date:  2005-12       Impact factor: 12.479

2.  Carbon nanotubes with high bone-tissue compatibility and bone-formation acceleration effects.

Authors:  Yuki Usui; Kaoru Aoki; Nobuyo Narita; Narumichi Murakami; Isao Nakamura; Koichi Nakamura; Norio Ishigaki; Hiroshi Yamazaki; Hiroshi Horiuchi; Hiroyuki Kato; Seiichi Taruta; Yoong Ahm Kim; Morinobu Endo; Naoto Saito
Journal:  Small       Date:  2008-02       Impact factor: 13.281

3.  Fabrication of hybrid scaffold based on hydroxyapatite-biodegradable nanofibers incorporated with liposomal formulation of BMP-2 peptide for bone tissue engineering.

Authors:  Marzieh Mohammadi; Mona Alibolandi; Khalil Abnous; Zahra Salmasi; Mahmoud Reza Jaafari; Mohammad Ramezani
Journal:  Nanomedicine       Date:  2018-06-19       Impact factor: 5.307

4.  Functionalized carbon nanotube reinforced scaffolds for bone regenerative engineering: fabrication, in vitro and in vivo evaluation.

Authors:  Paiyz E Mikael; Ami R Amini; Joysurya Basu; M Josefina Arellano-Jimenez; Cato T Laurencin; Mary M Sanders; C Barry Carter; Syam P Nukavarapu
Journal:  Biomed Mater       Date:  2014-03-31       Impact factor: 3.715

Review 5.  Growth factor delivery: how surface interactions modulate release in vitro and in vivo.

Authors:  William J King; Paul H Krebsbach
Journal:  Adv Drug Deliv Rev       Date:  2012-03-10       Impact factor: 15.470

6.  Enhanced osteogenic activity of poly(ester urea) scaffolds using facile post-3D printing peptide functionalization strategies.

Authors:  Shan Li; Yanyi Xu; Jiayi Yu; Matthew L Becker
Journal:  Biomaterials       Date:  2017-06-28       Impact factor: 12.479

7.  Terminal Group Modification of Carbon Nanotubes Determines Covalently Bound Osteogenic Peptide Performance.

Authors:  Cunyang Wang; Guangxiu Cao; Tianxiao Zhao; Xiumei Wang; Xufeng Niu; Yubo Fan; Xiaoming Li
Journal:  ACS Biomater Sci Eng       Date:  2020-01-15

8.  Collagen-infilled 3D printed scaffolds loaded with miR-148b-transfected bone marrow stem cells improve calvarial bone regeneration in rats.

Authors:  Kazim K Moncal; R Seda Tigli Aydin; Mohammad Abu-Laban; Dong N Heo; Elias Rizk; Scott M Tucker; Gregory S Lewis; Daniel Hayes; Ibrahim T Ozbolat
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2019-08-24       Impact factor: 7.328

9.  Aspirin enhances the osteogenic and anti-inflammatory effects of human mesenchymal stem cells on osteogenic BFP-1 peptide-decorated substrates.

Authors:  Yan Li; Zuyuan Luo; Xiao Xu; Yongliang Li; Siqi Zhang; Ping Zhou; Yi Sui; Minjie Wu; En Luo; Shicheng Wei
Journal:  J Mater Chem B       Date:  2017-08-18       Impact factor: 6.331

10.  The Application of Multi-Walled Carbon Nanotubes in Bone Tissue Repair Hybrid Scaffolds and the Effect on Cell Growth In Vitro.

Authors:  Jie Xu; Xueyan Hu; Siyu Jiang; Yiwei Wang; Roxanne Parungao; Shuangshuang Zheng; Yi Nie; Tianqing Liu; Kedong Song
Journal:  Polymers (Basel)       Date:  2019-02-01       Impact factor: 4.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.